{"title":"National survey of current intrauterine transfusion practices in India: Identifying gaps and actionable recommendations.","authors":"Sujal Agarwal, Shamee Shastry, Akhila Vasudeva, Ganesh Mohan, Deepika Chenna, Deep Madkaiker","doi":"10.1111/vox.70049","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Intrauterine transfusion (IUT) is a critical intervention for managing severe foetal anaemia, yet significant variability exists in transfusion protocols across India. This study aimed to evaluate the selection, processing and infusion protocols used by Indian transfusion medicine laboratories and foetal medicine teams for IUT, comparing them with international guidelines to develop best practice recommendations.</p><p><strong>Materials and methods: </strong>A cross-sectional survey was conducted among transfusion medicine and foetal medicine centres across India that had performed at least one IUT in the past 6 months. A structured questionnaire covering demographic data, transfusion medicine practices and foetal medicine protocols was distributed, and responses were analysed using descriptive statistics. A scoring system (0-4) was employed to assess adherence to best practices.</p><p><strong>Results: </strong>A total of 22 centres participated, with wide variability observed in transfusion practices. While 91% of centres used O RhD-negative blood, only 41% implemented extended phenotype matching. The targeted haematocrit (HCT) levels varied, with 75% preferred by most centres. Leucodepletion practices were inconsistent, and only 18% screened for cytomegalovirus (CMV). The majority of centres (59%) reported low complication rates, with foetal bradycardia being the most common adverse event. Success rates exceeded 80% in most centres; a gap analysis was done to derive the recommendations.</p><p><strong>Conclusion: </strong>The findings highlight the need for national guidelines for IUT practices in India. Recommendations include the use of pre-leucodepleted O RhD-negative red blood cells (RBCs), extended phenotype matching, fresh RBCs with HCT adjusted to 75%-80%, and mandatory irradiation. Implementing these best practices will standardize IUT services across India.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"831-840"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70049","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/25 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: Intrauterine transfusion (IUT) is a critical intervention for managing severe foetal anaemia, yet significant variability exists in transfusion protocols across India. This study aimed to evaluate the selection, processing and infusion protocols used by Indian transfusion medicine laboratories and foetal medicine teams for IUT, comparing them with international guidelines to develop best practice recommendations.
Materials and methods: A cross-sectional survey was conducted among transfusion medicine and foetal medicine centres across India that had performed at least one IUT in the past 6 months. A structured questionnaire covering demographic data, transfusion medicine practices and foetal medicine protocols was distributed, and responses were analysed using descriptive statistics. A scoring system (0-4) was employed to assess adherence to best practices.
Results: A total of 22 centres participated, with wide variability observed in transfusion practices. While 91% of centres used O RhD-negative blood, only 41% implemented extended phenotype matching. The targeted haematocrit (HCT) levels varied, with 75% preferred by most centres. Leucodepletion practices were inconsistent, and only 18% screened for cytomegalovirus (CMV). The majority of centres (59%) reported low complication rates, with foetal bradycardia being the most common adverse event. Success rates exceeded 80% in most centres; a gap analysis was done to derive the recommendations.
Conclusion: The findings highlight the need for national guidelines for IUT practices in India. Recommendations include the use of pre-leucodepleted O RhD-negative red blood cells (RBCs), extended phenotype matching, fresh RBCs with HCT adjusted to 75%-80%, and mandatory irradiation. Implementing these best practices will standardize IUT services across India.
期刊介绍:
Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:
1) Transfusion - Transmitted Disease and its Prevention:
Identification and epidemiology of infectious agents transmissible by blood;
Bacterial contamination of blood components;
Donor recruitment and selection methods;
Pathogen inactivation.
2) Blood Component Collection and Production:
Blood collection methods and devices (including apheresis);
Plasma fractionation techniques and plasma derivatives;
Preparation of labile blood components;
Inventory management;
Hematopoietic progenitor cell collection and storage;
Collection and storage of tissues;
Quality management and good manufacturing practice;
Automation and information technology.
3) Transfusion Medicine and New Therapies:
Transfusion thresholds and audits;
Haemovigilance;
Clinical trials regarding appropriate haemotherapy;
Non-infectious adverse affects of transfusion;
Therapeutic apheresis;
Support of transplant patients;
Gene therapy and immunotherapy.
4) Immunohaematology and Immunogenetics:
Autoimmunity in haematology;
Alloimmunity of blood;
Pre-transfusion testing;
Immunodiagnostics;
Immunobiology;
Complement in immunohaematology;
Blood typing reagents;
Genetic markers of blood cells and serum proteins: polymorphisms and function;
Genetic markers and disease;
Parentage testing and forensic immunohaematology.
5) Cellular Therapy:
Cell-based therapies;
Stem cell sources;
Stem cell processing and storage;
Stem cell products;
Stem cell plasticity;
Regenerative medicine with cells;
Cellular immunotherapy;
Molecular therapy;
Gene therapy.